非洲女性参与HIV-1暴露前预防试验中可治愈性传播感染发病率与HIV-1发病率的人群水平相关性
分析3256名参与口服和阴道PrEP试验安慰剂组的非洲女性数据,评估个体性传播感染发病率与HIV-1发病率的相关性。结果显示HIV-1发病率为4.9/100人年,淋病奈瑟菌5.3、沙眼衣原体14.5、阴道毛滴虫7.1/100人年;与沙眼衣原体的相关性主要由国家间差异驱动,国家内无统计学显著关联。结论认为性传播感染发病率不能可靠预测HIV-1发病率。
要点
- HIV-1发病率为4.9/100人年,沙眼衣原体发病率最高(14.5/100人年)。
- HIV-1发病率与淋病奈瑟菌(r=0.02,P=.871)和阴道毛滴虫(r=0.10,P=.481)相关性有限。
- 与沙眼衣原体的关联(r=0.49,P<.001)由国家级差异驱动,国家内无统计学显著关联。
核心结论
- 性传播感染发病率在参与2项大型PrEP试验的高危非洲女性中不能可靠预测人群水平的HIV-1发病率。
研究设计与样本
- 分析3256名随机分配至口服和阴道PrEP试验(MTN-003/VOICE和MTN-020/ASPIRE)安慰剂组的女性数据。
- 采用回归模型评估个体性传播感染(淋病奈瑟菌、沙眼衣原体、阴道毛滴虫分别考虑)与HIV-1发病率的相关性。
主要发现
- 在4个国家(马拉维、南非、乌干达、津巴布韦)的18个中心,HIV-1发病率为4.9/100人年,淋病奈瑟菌5.3/100人年,沙眼衣原体14.5/100人年,阴道毛滴虫7.1/100人年。
- HIV-1发病率与淋病奈瑟菌发病率相关性有限(r=0.02,P=.871)。
- HIV-1发病率与沙眼衣原体发病率相关性有限(r=0.49,P<.001)。
- HIV-1发病率与阴道毛滴虫发病率相关性有限(r=0.10,P=.481)。
- 与沙眼衣原体的适度关联由沙眼衣原体和HIV-1的国家级差异驱动,国家内无统计学显著关联。
关键数值与推荐
- HIV-1发病率4.9/100人年,淋病奈瑟菌5.3/100人年,沙眼衣原体14.5/100人年,阴道毛滴虫7.1/100人年。
- 淋病奈瑟菌与HIV-1发病率相关系数r=0.02,P=.871。
- 沙眼衣原体与HIV-1发病率相关系数r=0.49,P<.001。
- 阴道毛滴虫与HIV-1发病率相关系数r=0.10,P=.481。
临床怎么用
- 原文未据此给出推荐。
局限性
- 与沙眼衣原体的适度关联由国家级差异驱动,国家内无统计学显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Highly efficacious oral pre-exposure prophylaxis (PrEP) is the global standard for human immunodeficiency virus (HIV)-1 prevention, including in clinical trials of novel PrEP agents using active-comparator designs. The analysis assessed whether incident sexually transmitted infections (STIs) can serve as a surrogate indicator of HIV-1 incidence that might occur in the absence of PrEP. METHODS: We analyzed data from 3256 women randomized to placebo groups of oral and vaginal PrEP trials (MTN-003/VOICE and MTN-020/ASPIRE). Regression modeling assessed the correlation between incident individual STIs (Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis, each considered separately) and incident HIV-1. RESULTS: Across 18 sites in 4 countries (Malawi, South Africa, Uganda, Zimbabwe), STI and HIV-1 incidences were high: HIV-1 4.9, N gonorrhoeae 5.3, C trachomatis 14.5, and T vaginalis 7.1 per 100 person-years. There was limited correlation between HIV-1 incidence and incidence of individual STIs: N gonorrhoeae (r = 0.02, P = .871), C trachomatis (r = 0.49, P = <.001), and T vaginalis (r = 0.10, P = .481). The modest association with C trachomatis was driven by country-level differences in both C trachomatis and HIV-1, with no statistically significant association within countries. CONCLUSIONS: Sexually transmitted infection incidence did not reliably predict HIV-1 incidence at the population level among at-risk African women participating in 2 large PrEP trials.
引用
- Hunidzarira P, Brown ER, Chirenje ZM, et al. Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials. J Infect Dis. 2022. PMID: 35763413. doi:10.1093/infdis/jiac269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。